Hengyi Yu

Hengyi Yu

Auto-generated profile, based on publicly available information

Hengyi Yu

Department of Pharmacy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China; and

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2023 in Heliyon
Verified
Journal Article
Open access
HYHengyi Yu
Hengyi Yu
DLDongyan Li
Dongyan Li
DXDong Xiang
Dong Xiang
XLXiping Li
Xiping Li
LLLu Liu
Lu Liu
XGXuepeng Gong
Xuepeng Gong
A rapid, specific and accurate high-performance liquid chromatography with tunable ultraviolet detection method was developed to simultaneously determine azathioprine metabolites, 6-thioguanine nucleotides (6-TGN) and 6-methyl mercaptopurine riboside (6-MMPr) in human red blood cells. Erythrocyte lysate sample was precipitated by perchloric acid under the protection of dithiothreitol, with 6-TGN and 6-MMPr being acid hydrolyzed to produce 6-thioguanine (6-TG) and 6-methymercaptopurine (6-MMP). A Waters Cortecs C18 column (2.1 × 150 mm, 2.7 μm) was used for chromatographic separation with a water (containing 0.01 mol/L ammonium acetate and 0.2% acetic acid)/methanol linear gradient at a flow rate of 0.45 mL/min in a 5.5 min. UV detection wavelengths were 340 nm for 6-TG, 303 nm for 6-MMP and the IS (5-bromouracil). The calibration curves fitted a least squares model (weighed 1/x 2) from 0.15 to 15 μmol/L for 6-TG (r 2 = 0.9999) and from 1 to 100 μmol/L for 6-MMP (r 2 = 0.9998). This method was validated according to the FDA bioanalytical method validation guidance and ICH M10 bioanalytical method validation and study sample analysis guidance for industry, and successfully utilized in ten IBD patients receiving azathioprine therapy.

25 April 2023 in Acta Chromatographica
Verified
Journal Article
Open access
PDF file
HYHengyi Yu
Hengyi Yu
XRXiuhua Ren
Xiuhua Ren
LLLu Liu
Lu Liu
DXDong Xiang
Dong Xiang
XLXiping Li
Xiping Li
GXGong XuePeng
Gong XuePeng
Epilepsy is one of the most prevalent neurological conditions and antiepileptic drugs are the mainstay of epilepsy treatment. High variation in pharmacokinetic profiles of several antiepileptic drugs highlights the importance of therapeutic drug monitoring to estimate pharmacokinetic properties and consequently individualize drug posology. In this work, a simple, rapid and robust liquid chromatography-tandem mass spectrometry method was developed for simultaneous quantification of carbamazepine and its metabolite carbamazepine-10,11-epoxide, gabapentin, levetiracetam, lamotrigine, oxcarbazepine and its metabolite mono-hydroxy-derivative metabolite, phenytoin, topiramate, and valproic acid in human plasma for therapeutic drug monitoring. d6-Levetiracetam, d4-gabapentin and d6-valproic acid were used as internal standards. After addition of internal standards along with two-step protein precipitation and dilution sample preparation, plasma samples were analyzed on a C18 column using a gradient elution in 5 min without interference. The calibration curves were linear over a 100-fold concentration range, with determination coefficients (r2) greater than 0.99 for all analytes. The limit of quantification was 0.5 μg mL−1 (0.1 μg mL−1 for oxcarbazepine, 2 μg mL−1 for levetiracetam, and 10 μg mL−1 for valproic acid) with precision and accuracy ranging from 3% to 9% and from 94% to 112%, respectively. Intra- and inter-day precision and accuracy values were within 15% at low, medium and high quality control levels. No significant matrix effect was observed in the normal, hemolyzed, lipemic, and hyperbilirubin blood samples. This method was successfully used in the identification and quantitation of antiepileptic drugs in patients undergoing mono- or polytherapy for epilepsy.

23 May 2025 in Therapeutic Drug Monitoring
Verified
Journal Article
Closed access
HYHengyi Yu
Hengyi Yu
QHQun Hu
Qun Hu
LLLu Liu
Lu Liu
DXDong Xiang
Dong Xiang
GYGuangjie Yang
Guangjie Yang
XGXuepeng Gong
Xuepeng Gong
Background: Acute lymphoblastic leukemia (ALL) is the predominant malignancy in pediatric patients. As a crucial constituent of ALL chemotherapy, l -asparaginase is recognized as an integral element of treatment with a threshold concentration of 0.1 IU/mL used in treatment protocols. This study presents a novel liquid chromatography–tandem mass spectrometry method for evaluating plasma l -asparaginase activity in pediatric patients with ALL undergoing pegaspargase therapy. Methods: Initially, an enzyme incubation was conducted using 20 μL of plasma and 100 μL of l -asparagine (0.1 mol/L) at 37°C for 15 minutes. The reaction was stopped by adding sulfosalicylic acid and methanol. After the addition of isotope internal standard l -aspartic 13 C 4 acid, subsequent centrifugation, and dilution, the plasma samples underwent analysis by liquid chromatography–tandem mass spectrometry on a hydrophilic interaction liquid chromatography analytical column. A flow rate of 0.3 mL/min was used during isocratic elution using a mobile phase consisting of methanol–water (95:5, vol/vol) with 0.2% formic acid within a 5-minute run. Results: The calibration curves exhibited excellent linearity ranging from 0.1 to 15 IU/mL, with determination coefficients ( r 2 ) exceeding 0.99. The precision and accuracy ranged from 1% to 7% and from 93% to 110%, respectively. The relative recovery fell within the range of 98%–100%, and the internal standard–normalized matrix effect ranged from 95% to 101%. The stability was satisfactory across various conditions. Conclusions: This method was fully validated and successfully applied to quantify l -asparaginase activity in plasma samples of 15 children with ALL, enabling the monitoring of l -asparaginase activity with mass spectrometry.

25 June 2026 in Journal of open systems evolution problems
Verified
Journal Article
Open access
PDF file
UJU. Jenis
U. Jenis
YSYе. Shybyray
Yе. Shybyray
CZCh. Zhang
Ch. Zhang
HYH. Yu
H. Yu
SDS. Duzelbayeva
S. Duzelbayeva
JJJanar Jenis
Janar Jenis
Artemisia rutifolia Steph. ex Spreng. has a long history of folk medicinal usage in Kazakhstan, although rigorous study into its chemical makeup is still restricted. This study used the aerial portions of Artemisia rutifolia in Almaty Region, Kazakhstan, to determine the amounts of basic physicochemical indicators, mineral elements, and important secondary metabolites using the Kazakh National Pharmacopoeia's procedures. Chemical components in the petroleum ether and dichloromethane phases were separated and identified using gas chromatography-mass spectrometry (GC-MS), followed by compound comparison and qualitative identification using the NIST14 and Wiley standard mass spectrometry databases. The analysis showed that the plant sample extracted with 50% ethanol contained 7.42% moisture, 4.58% total ash, and 35.76%. Coumarin showed the highest concentration (2.53%), followed by polysaccharides (1.30%), and saponins (1.16%). The mineral elements were primarily K (65.41 mg/100 g) and Ca (39.41 mg/100 g), with heavy metals Pb, Cd, and Ni being below WHO limits. The petroleum ether fraction contained twenty-eight compounds, the majority of which were methoxybenzene derivatives (43.80%), while the dichloromethane fraction contained 63 compounds, including methoxybenzene derivatives (25.82%), scopoletin (3.00%), sesquiterpene lactones such as ambrosin (3.36%), and various phenolic acids. In summary, A. rutifolia from this location has a variety of bioactive components having therapeutic properties. The petroleum ether fraction consists primarily of aromatic and steroidal chemicals, whereas the dichloromethane fraction is rich in sesquiterpene lactones and phenolic acids. More research into its chemical composition and active ingredients will follow.

1 July 2023 in Heliyon
Verified
Journal Article
Open access
HYHengyi Yu
Hengyi Yu
XQXingxing Qi
Xingxing Qi
YFYinian Fang
Yinian Fang
KWKaifu Wang
Kaifu Wang
DZDonglin Zhang
Donglin Zhang
XRXiuhua Ren
Xiuhua Ren
Somnolence is a common adverse effect of antipsychotic drugs used to treat psychotic disorders. It causes problems in many areas of life, such as gainful employment, driving, childcare, and social interactions. Somnolence is a major problem for a relatively new antipsychotic drug, lurasidone, whose dose-effect relationship remains unclear. Based on data from a bioequivalence study of two 40 mg lurasidone hydrochloride tablets, we designed two case-control studies to explore the correlation between somnolence and exposure to lurasidone and determine the factors associated with lurasidone-induced somnolence. In the first case-control study, lurasidone was administered to healthy volunteers; 30 experienced somnolence (as pre-defined) but 29 did not. Moreover, plasma concentration at 1 h was significantly associated with somnolence (OR = 1.124; p = 0.001). In the second case-control study, 48 volunteers administered lurasidone were classified into somnolence and no-somnolence groups based on different time-related criteria. We observed a positive association between plasma concentration at 0.75 h and somnolence (OR = 1.024; p = 0.002). Receiver operating characteristic analysis revealed that a plasma lurasidone concentration >21.65 ng/mL 1 h after administration strongly predicted somnolence. Our findings in healthy volunteers need to be further validated in patients in clinical settings to determine the optimal dose and duration of lurasidone administration.